Immediate Impact

1 by Nobel laureates 12 from Science/Nature 69 standout
Sub-graph 1 of 23

Citing Papers

Tumour vasculature at single-cell resolution
2024 StandoutNature
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
2 intermediate papers

Works of Eric D. Mininberg being referenced

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer
2005
977 Phase I/II trial evaluating blockade of tumour blood supply and tumour cell proliferation with combined bevacizumab and erlotinib HCl as targeted cancer therapy in patients with recurrent non-small cell lung cancer
2003

Author Peers

Author Last Decade Papers Cites
Eric D. Mininberg 304 340 97 194 6 489
Teresa M. Hopper 223 195 98 238 6 467
Amy E. Hanna 186 298 98 306 6 528
James A. Onori 226 211 119 248 4 478
Rinat Galiulin 385 367 108 135 7 550
Minhao Fan 265 304 133 174 11 526
Magda Bahcall 318 274 65 376 13 571
Trine Lindsted 156 251 87 204 9 426
Linda Mahjoubi 203 362 130 207 12 543
Maria S. Romero 265 292 56 235 6 493
Lucía Regales 301 280 69 243 10 448

All Works

Loading papers...

Rankless by CCL
2026